<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e>) is an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> condition which may involve the cardiovascular, ocular, skeletal, and other systems </plain></SENT>
<SENT sid="1" pm="."><plain>Mutations causing <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> are found in the FBN1 gene, encoding fibrillin-1, an extracellular matrix protein involved in microfibril formation </plain></SENT>
<SENT sid="2" pm="."><plain>In the most severe cases, mutations are generally found in exons 24-32, and children with these mutations usually die in the first years of life, of <z:e sem="disease" ids="C1444565" disease_type="Disease or Syndrome" abbrv="">cardiopulmonary failure</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>We present clinical, molecular and histopathological studies on a patient with severe early <z:hpo ids='HP_0003674'>onset</z:hpo> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MFS</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>He has a mutation in exon 25 of FBN1, a G&gt;A transition at nucleotide position 3131 that converts the codon TGC, coding for cysteine at position 1044, to <z:chebi fb="44" ids="53498">TAC</z:chebi>, coding for tyrosine (C1044Y) </plain></SENT>
<SENT sid="5" pm="."><plain>This has resulted in abnormalities of the extracellular matrix and a severe clinical phenotype, although he has survived to the age of 14 years </plain></SENT>
</text></document>